EGH Acquisition Corp. Class A Ordinary Shares (EGHA) vs Solana Company (HSDT)
A side-by-side comparison of EGH Acquisition Corp. Class A Ordinary Shares and Solana Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EGHA
EGH Acquisition Corp. Class A Ordinary Shares
$10.44Financial ServicesDelayed quote: Oct 6, 2026, 10:22 AM EDT
HSDT
Solana Company
$2.69Financial ServicesDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — EGHA vs HSDT
growth of $100 · dividends reinvested · last 1yEGHA +4.3% (+4.3%/yr)HSDT -83.5% (-83.5%/yr)EGHA compounded faster over this window
Log scale — wide-divergence pair
EGHA HSDT
EGHA vs HSDT: by the numbers
- •EGHA is the larger company ($162M vs $157M market cap).
- •Both run net losses; EGHA's is the smaller (0.00% vs -1302.78% net margin).
Metrics side by side
Valuation
| Metric | EGHA | HSDT |
|---|---|---|
| P/E ratio | 46.54 | N/A |
| P/S ratio | N/A | 13.01 |
| P/B ratio | 1.08 | 0.95 |
Profitability
| Metric | EGHA | HSDT |
|---|---|---|
| Gross margin | 0.00% | 95.53% |
| Operating margin | 0.00% | -351.02% |
| Net margin | 0.00% | -1302.78% |
| ROE | 1.75% | -94.95% |
| ROIC | -1.30% | N/A |
Growth (annualized)
| Metric | EGHA | HSDT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 90.85% |
| Total return CAGR (5Y) | N/A | -91.26% |
Go deeper
Dig into the metrics
EGH Acquisition Corp. Class A Ordinary Shares P/E ratioEGH Acquisition Corp. Class A Ordinary Shares ROESolana ROEEGH Acquisition Corp. Class A Ordinary Shares operating marginSolana operating marginEGH Acquisition Corp. Class A Ordinary Shares revenue growthSolana revenue growthEGH Acquisition Corp. Class A Ordinary Shares free cash flow
EGH Acquisition Corp. Class A Ordinary Shares & Solana appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.